Phallacidin is a bicyclic heptapeptide toxin derived from poisonous mushrooms. Phallacidin stabilizes microfilament structures and inhibits actin depolymerization by binding with high affinity to filamentous actin (F-actin), thereby disrupting cytoskeletal dynamics. Phallacidin can be used for cytoskeleton visualization research, fluorescent probe development, and studies on microfilament dynamics mechanisms[1-4].
References:
[1] Schmid E, Gu S, Yang W, et al. Serum- and glucocorticoid-inducible kinase SGK1 regulates reorganization of actin cytoskeleton in mast cells upon degranulation. Am J Physiol Cell Physiol. 2013 Jan 1;304(1):C49-55.
[2] Franzén LE. The perforated mesentery of the rat: a novel model for the study of genuine connective tissue contraction. J Surg Res. 1996 Jan;60(1):91-100.
[3] Carley WW, Barak LS, Webb WW. F-actin aggregates in transformed cells. J Cell Biol. 1981 Sep;90(3):797-802.
[4] Hinshaw DB, Sklar LA, Bohl B, et al. Cytoskeletal and morphologic impact of cellular oxidant injury. Am J Pathol. 1986 Jun;123(3):454-64.
Phallacidin是一种来源于毒蘑菇的双环七肽毒素。Phallacidin通过高亲和力结合丝状肌动蛋白(F-actin)来稳定微丝结构并抑制肌动蛋白解聚,从而破坏细胞骨架动态平衡。Phallacidin可用于细胞骨架可视化研究、荧光探针开发和微丝动力学机制研究[1-4]。
















